Vijender Panduga
AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Cancer therapeutics and mechanisms, Biochemical and Molecular Research, Pharmacogenetics and Drug Metabolism, Malaria Research and Control
Most-Cited Works
- → Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo(2013)161 cited
- → Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis(2017)124 cited
- → 1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis(2014)109 cited
- → 4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity(2014)94 cited
- → Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents(2014)89 cited
- → In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis(2013)80 cited
- → Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate(2015)73 cited
- → Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B(2013)66 cited
- → Benzimidazoles: Novel Mycobacterial Gyrase Inhibitors from Scaffold Morphing(2014)57 cited
- → Novel N-Linked Aminopiperidine-Based Gyrase Inhibitors with Improved hERG and in Vivo Efficacy against Mycobacterium tuberculosis(2014)51 cited